Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer
Technology in Cancer Research & Treatment · 2024-01 · 23
DOI: 10.1177/15330338241260646 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 06.06.2024. Verfasst von Ferda Yamic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. Hauptthemen laut MEDLINE: Oropharyngeal Neoplasms, Parotid Gland, Radiotherapy Dosage, Organs at Risk. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
The purpose of this research was to compare two treatment techniques for oropharyngeal cancers: conventional linac-based static intensity-modulated radiotherapy (sIMRT) and helical tomotherapy (HT). The study examined several parameters, including target coverage, organs at risk, integral dose, and beam on time. Additionally, the study evaluated the doses to the parotid, temporomandibular joint, and pharyngeal constrictor muscles, which are important for swallowing.
Method
The present study retrospectively analyzed the data of 13 patients with oropharyngeal cancer who underwent radiotherapy between 2019 and 2021. The treatment plans for each patient were regenerated using both sIMRT and HT treatment planning systems with the sequential boost method. The techniques were evaluated and compared based on dose-volume histogram, homogeneity index, and conformity index parameters. The target coverage and organs at risk were statistically compared for two techniques. Additionally, the doses received by the healthy tissue volume were obtained for integral dose evaluation. The beam on time for each technique was assessed.
Results
When considering planning target volume evaluation, there was no difference in D means between the two techniques and sIMRT demonstrated higher D 2% values compared to the HT. The HT technique had better results for all organs at risk, such as the parotid, temporomandibular joint, and pharyngeal constrictor muscle. As for integral dose, it has been shown that the sIMRT technique provides better protection compared to HT. In addition, the beam on time was also longer with the HT technique.
Conclusion
Both techniques may provide optimal target coverage for patients with oropharyngeal cancer. HT conferred notable advantages, especially with regard to critical structures implicated in swallowing, such as the parotid, temporomandibular joint, and pharyngeal constrictor muscle, in comparison to sIMRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
- Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya, Turkey.
ORCID-Profile: Timur Koca
Zitieren
APA
Yamic, F., Koca, T., Tuncel, N., Aksoy, R. A., & Korcum, A. F. (2024). Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241260646
Vancouver
Yamic F, Koca T, Tuncel N, Aksoy RA, Korcum AF. Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer. Technology in Cancer Research & Treatment. 2024;23. doi:10.1177/15330338241260646
BibTeX
@article{Yamic2024,
author = {Yamic, Ferda and Koca, Timur and Tuncel, Nina and Aksoy, Rahmi Atil and Korcum, Aylin Fidan},
title = {Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
volume = {23},
doi = {10.1177/15330338241260646}
}
EUVIMED